Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase
California Institute of Technology · Johns Hopkins University · +7 more institutions
Abstract
Amyloid precursor protein (APP) is endoproteolytically processed by BACE1 and gamma-secretase to release amyloid peptides (Abeta40 and 42) that aggregate to form senile plaques in the brains of patients with Alzheimer's disease (AD). The C-terminus of Abeta40/42 is generated by gamma-secretase, whose activity is dependent upon presenilin (PS 1 or 2). Missense mutations in PS1 (and PS2) occur in patients with early-onset familial AD (FAD), and previous studies in transgenic mice and cultured cell models demonstrated that FAD-PS1 variants shift the ratio of Abeta40 : 42 to favor Abeta42. One hypothesis to explain this outcome is that mutant PS alters the specificity of gamma-secretase to favor production of…
Citation impact
- FWCI
- 7.46
- Percentile
- 100%
- References
- 80
Authors
12- JLJoanna L. JankowskyCorresponding
California Institute of Technology, Johns Hopkins University, Johns Hopkins Medicine
- DJDaniel J. Fadale
Jacksonville College, WinnMed, Mayo Clinic in Florida
- JCJeffrey C. Anderson
Merck Biopharma Co., Ltd. (Japan)
- GXGuilian Xu
Johns Hopkins University
- VGVictoria Gonzales
Johns Hopkins University
Topics & keywords
- Presenilin
- Mutant
- Biology
- Genetically modified mouse
- Amyloid precursor protein
- In vivo
- Missense mutation
- P3 peptide